Hedge Fund and Insider Trading News: Jonathan Litt, Mike Novogratz, The Medicines Company (MDCO), Checkpoint Therapeutics Inc (CKPT), Koppers Holdings Inc. (KOP), and More

Insider Buying: Checkpoint Therapeutics Inc (NASDAQ:CKPT) Director Buys 100,000 Shares of Stock (FairFieldCurrent.com)
Checkpoint Therapeutics Inc (NASDAQ:CKPT) Director Lindsay A. Md Rosenwald bought 100,000 shares of the firm’s stock in a transaction on Friday, November 9th. The shares were acquired at an average cost of $2.29 per share, with a total value of $229,000.00. The acquisition was disclosed in a filing with the SEC.

Insider Buying: The Medicines Company (NASDAQ:MDCO) EVP Buys 50,300 Shares of Stock (MareaInformativa.com)
The Medicines Company (NASDAQ:MDCO) EVP Christopher T. Cox acquired 50,300 shares of the firm’s stock in a transaction dated Friday, November 16th. The stock was bought at an average cost of $19.73 per share, for a total transaction of $992,419.00. Following the purchase, the executive vice president now directly owns 60,308 shares of the company’s stock, valued at $1,189,876.84. The purchase was disclosed in a filing with the Securities & Exchange Commission.

Insider Buying: Koppers Holdings Inc. (KOP) VP Purchases 50,000 Shares of Stock (PressOracle.com)
Koppers Holdings Inc. (NYSE:KOP) VP R. Michael Johnson acquired 50,000 shares of the firm’s stock in a transaction dated Monday, November 12th. The shares were purchased at an average cost of $20.16 per share, with a total value of $1,008,000.00. Following the completion of the transaction, the vice president now owns 96,534 shares in the company, valued at approximately $1,946,125.44. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Insider Buying: Great Elm Capital Corp (GECC) Insider Purchases 61,500 Shares of Stock (MareaInformativa.com)
Great Elm Capital Corp (NASDAQ:GECC) insider Peter A. Reed purchased 61,500 shares of the stock in a transaction that occurred on Monday, November 19th. The stock was acquired at an average cost of $8.08 per share, for a total transaction of $496,920.00. The purchase was disclosed in a filing with the Securities & Exchange Commission.

Insider Selling: Esperion Therapeutics Inc (NASDAQ:ESPR) Major Shareholder Sells $5,638,000.00 in Stock (FairFieldCurrent.com)
Esperion Therapeutics Inc (NASDAQ:ESPR) major shareholder Boxer Capital, Llc sold 100,000 shares of the stock in a transaction on Monday, November 5th. The shares were sold at an average price of $56.38, for a total value of $5,638,000.00. The transaction was disclosed in a document filed with the SEC.